id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-322732-82m84n4w	Felice, C	Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives	2020-06-08		.txt	text/plain	1770	113	49	We aimed to investigate the association between chronic use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) and COVID-19 related outcomes in hypertensive patients. Additional analyses were performed after grouping patients taking ACEIs and ARBs and comparing their clinical outcomes with those A c c e p t e d M a n u s c r i p t 5 of hypertensives who were not on RAAS inhibitors. The present study shows that chronic assumption of ACEIs/ARBs did not worsen the clinical outcomes of COVID-19 infection in hypertensive patients. A significant lower risk of admission to s-ICU/ICU was observed in COVID-19 positive subjects chronically treated with ACEIs/ARBs as compared to other hypertensive patients, whereas the rates of hospitalization, oxygen therapy, non-invasive ventilation and death did not differ between the two groups. Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China	./cache/cord-322732-82m84n4w.txt	./txt/cord-322732-82m84n4w.txt